Synaptic Pathway Training for Depression Treatment
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for depression, bipolar disorder, and alcoholism are ineffective for many patients, providing only short-term relief and often come with significant side effects, and do not address the underlying causes of these conditions.
Innovation Solution
A method involving synaptic pathway training, which includes administering a pharmacologic agent such as ketamine to activate synaptic pathways and combining it with cognitive or external stimulation to prolong the treatment effects, thereby increasing synaptic density and volume in the hippocampus, reducing symptoms and urges over an extended period.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Duration of action of moving object
If traditional treatments (CBT, medications, ECT) are used for depression, then some patients experience symptom relief, but the relief is short-lived and side effects occur
Solution Approach 1:
The patent applies preliminary action by administering a pharmacologic agent (such as ketamine) before the cognitive training exercise. This preliminary pharmacologic activation of synaptic pathways creates a primed state that enhances the subsequent training effects and prolongs symptom relief duration.
Solution Approach 2:
The patent merges pharmacologic treatment with cognitive training exercise into a combined therapeutic approach. This combination synergistically enhances the treatment effects compared to either modality alone, providing both immediate symptom relief and long-lasting structural changes in the hippocampus.
2Loss of time
If medications are used to treat depression, then symptoms may be managed, but the therapeutic effect is gradual and medications must be taken lifelong
Solution Approach 1:
The pharmacologic agent is administered as a preliminary action that rapidly activates synaptic pathways, producing immediate symptom relief rather than the gradual effect of traditional medications. This preliminary activation creates lasting structural changes that extend the treatment effect duration.
Solution Approach 2:
The patent establishes continuity of useful action through the combination of rapid pharmacologic effect and subsequent cognitive training that maintains and extends the therapeutic state. The synaptic pathway training continues the beneficial action beyond the initial drug effect, providing long-lasting relief without requiring lifelong medication.
3Speed
If ECT is used for depression, then immediate symptom relief is achieved, but brain damage and cognitive impairment occur
Solution Approach 1:
The patent replaces the mechanical/electrical mechanism of ECT with a pharmacologic and cognitive training approach. Instead of using electrical current to induce seizures for rapid symptom relief, the method uses pharmacologic agents to activate synaptic pathways followed by cognitive training, achieving similar rapid effects without the harmful side effects of brain damage and cognitive impairment.
4Adaptability or versatility
If cognitive behavioral therapy is used for depression, then mild to moderate symptoms improve, but chronic or severe depression responds poorly
Solution Approach 1:
The patent merges pharmacologic treatment with cognitive training exercise to create a combined approach that is effective across all depression severities. The pharmacologic agent provides rapid activation of synaptic pathways that works synergistically with cognitive training, enhancing effectiveness for chronic and severe depression compared to CBT alone.
Solution Approach 2:
The patent changes the parameter of treatment mechanism by introducing pharmacologic activation that modifies synaptic pathway function. This parameter change enables the treatment to be effective across different depression severities by fundamentally altering the neurochemical state, making the treatment adaptable to both mild and severe cases.
Data Source
AI summary
Disclosed are methods of treating depression, mania, post-traumatic stress disorder (PTSD), and various other neurologic conditions using synaptic pathway training. Methods of synaptic pathway training include, generally, achieving a favorable treatment result by activating a synaptic pathway using a pharmacologic agent, such as treating refractory symptoms of depression with ketamine, following by potentiation of the favorable result by repeatedly stimulating the activated pathway. Stimulation of a synaptic pathway may be achieved by intrinsic means, such as performance of cognitive exercised, or extrinsic means, such as by delivery of a sensory stimulus to the patient, placing a potential voltage difference across the brain or a brain region, or by placing the brain or a brain region in a magnetic field.